Covance Recognized for Outstanding Customer Service by Eli Lilly and Company

View printer-friendly version << Back

— Covance Clinical Research Unit in Leeds receives Lilly's 2008 Global Supplier Award —

PRINCETON, NJ, July 31, 2008 Covance (NYSE: CVD), a leading provider of drug development services, today announced that its clinical pharmacology services were recognized for outstanding customer service by Eli Lilly and Company.

Covance's clinical research unit based in Leeds, UK received Lilly's 2008 Global Supplier Award, which acknowledges and encourages the contributions of key suppliers that contribute the best in innovation and technology towards Lilly's success.

Covance is one of a select group of suppliers to Lilly that has demonstrated its commitment to helping the company meet its corporate objectives. Covance was judged by a committee of Lilly representatives on criteria including supplier relationship management, quality, speed, service, cost reduction, and supplier diversity.

"We are honored to receive such a high level of recognition from one of the world's most prominent pharmaceutical companies," said Mary Westrick, Covance Global Vice President and General Manager of Clinical Pharmacology. "Covance is proud that our pharmaceutical clients consider us integral partners in their important development of new therapies and cures."

Covance's clinical pharmacology service offering evaluates the safety and efficacy of potential new drugs in humans, including the conduct of first-in-human trials. Covance has pioneered many of the specialized services in its diversified portfolio of drug development services and that uniquely positions the company as a valued partner in helping to progress compounds from preclinical to proof-of-concept studies.

About Covance
Covance, with headquarters in Princeton, New Jersey, is one of the world's largest and most comprehensive drug development services companies with annual revenues greater than $1.5 billion, global operations in more than 20 countries, and nearly 9,000 employees worldwide. Information on Covance's products and services, recent press releases, and SEC filings can be obtained through its website at www.covance.com.